UBS AM’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.11M Buy
266,893
+81,657
+44% +$951K ﹤0.01% 1942
2025
Q1
$1.38M Buy
185,236
+66,643
+56% +$495K ﹤0.01% 2173
2024
Q4
$711K Buy
+118,593
New +$711K ﹤0.01% 2471
2024
Q2
Sell
-203,941
Closed -$655K 2796
2024
Q1
$655K Buy
203,941
+32,649
+19% +$105K ﹤0.01% 2200
2023
Q4
$839K Hold
171,292
﹤0.01% 2120
2023
Q3
$934K Buy
171,292
+48,375
+39% +$264K ﹤0.01% 1990
2023
Q2
$1.09M Hold
122,917
﹤0.01% 1965
2023
Q1
$1.09M Buy
122,917
+10,731
+10% +$94.8K ﹤0.01% 1965
2022
Q4
$857K Buy
112,186
+2,457
+2% +$18.8K ﹤0.01% 1919
2022
Q3
$781K Buy
109,729
+3,329
+3% +$23.7K ﹤0.01% 2113
2022
Q2
$861K Sell
106,400
-65,243
-38% -$528K ﹤0.01% 2048
2022
Q1
$2.38M Buy
171,643
+16,285
+10% +$226K ﹤0.01% 1711
2021
Q4
$4.36M Buy
155,358
+4,558
+3% +$128K ﹤0.01% 1483
2021
Q3
$5.13M Buy
150,800
+2,394
+2% +$81.4K ﹤0.01% 1341
2021
Q2
$6.06M Sell
148,406
-130,715
-47% -$5.34M ﹤0.01% 1288
2021
Q1
$11.2M Buy
279,121
+1,364
+0.5% +$54.9K 0.01% 1047
2020
Q4
$16.4M Buy
277,757
+32,266
+13% +$1.91M 0.01% 897
2020
Q3
$11.9M Buy
245,491
+10,779
+5% +$524K 0.01% 900
2020
Q2
$11.4M Buy
234,712
+170,766
+267% +$8.26M 0.01% 872
2020
Q1
$1.78M Buy
63,946
+12,923
+25% +$359K ﹤0.01% 1459
2019
Q4
$1.53M Sell
51,023
-280
-0.5% -$8.38K ﹤0.01% 1719
2019
Q3
$1.59M Buy
51,303
+1,303
+3% +$40.3K ﹤0.01% 1722
2019
Q2
$2.42M Buy
+50,000
New +$2.42M ﹤0.01% 1489